Skip to main content

Policy Outlook: Understanding the Environment for Pricing and Access to Medicines During an Election Year

Tuesday, February 27, 2024
Majestic Complex
As Congressional and Presidential elections approach, pricing and access to medicines are topics of great interest and debate to different constituencies. Attend this conversation among dynamic stakeholders to review the impact of prescription drug affordability boards in states, reimbursement pathways for novel therapeutics, and how federal rulemaking all impact the future and financing of R&D in the industry.
John Murphy, Chief Policy Officer - BIO
Lindsay Androski, President and CEO - Roivant Social Ventures
Erin Estey Hertzog, Partner - Foley Hoag
Michael Ward, Vice President of Public Policy and Government Relations - Alliance for Aging Research
Rick Weissenstein, Managing Director, Washington Research Group - Health Care Services & Pharmaceutical Policy - TD Cowen Washington Research Group
Chris Mancill, SVP & Head, Global Market Access, Pricing, and Value Demonstration - Bristol Myers Squibb

Double Helix


Supporting Bank Sponsor


Premier Sponsors

Conference Sponsors


Media Partner


Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.